Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
ICICI Bank Limited (IBN - Analyst Report) reported 2010 fiscal fourth quarter and full fiscal year (ended March 31) last week. For the fourth quarter, profit increased 35% year over year to INR10.06 billion (US$224 million). For full fiscal year 2010, ICICI Bank reported a profit of INR40.25 billion (US$896 million), up 7% year over year.
Quarterly results were primarily driven by an increase in fee income, a drop in loss provisions and reduced operating expenses. Asset quality showed signs of improvement while capital levels remained good.
ICICI Bank reported an improvement in asset quality. Net non-performing assets were down 11.7% sequentially and 15.5% year over year to INR39.01 billion (US$869 million) as of March 31, 2010. The bank's net non-performing asset ratio was at 1.87%, down 32 basis points sequentially. In addition, there was a 1% sequential and 9% year-over-year decrease in the provision for losses to INR9.9 billion (US$220 million).
Net interest income decreased approximately 5% year over year to INR20.35 billion (US$453 million). Fee income increased 13% year over year to INR15.21 billion (US$339 million).
The company reported a decrease in both its loan book and total deposits. The loan book was down to INR1812.06 billion (US$40.4 billion) as of Mar 31, 2010 from INR 2,183.11 billion (US$48.6 billion) as of Mar 31, 2009, reflecting repayments from the retail loan portfolio and the loan portfolio of overseas branches.
Total deposits were down to INR2,020.17 billion (US$45.0 billion) as of Mar 31, 2010, compared with INR2,183.48 billion (US$48.6 billion) as of Mar 31, 2009.
However, ICICI Bank has reported growth in current and savings account (CASA) deposits and an increase in CASA ratio. CASA deposits grew 34% year over year to INR842.16 billion (US$18.8 billion) as of Mar 31, 2010. The CASA ratio increased to 41.7% as of Mar 31, 2010 from 28.7% as of Mar 31, 2009.
Operating expenses were well controlled and reported a decrease of 6% year-over year to INR15.04 billion (US$335 million).
As of Mar 31, 2010, ICICI Bank's capital adequacy as per the Reserve Bank of India's Basel II norms was 19.4% and Tier-1 capital adequacy was 14.0%, well above the requirements of 9.0% and 6.0%, respectively.
Get the full Analyst Report on IBN - FREE